Bisoprolol Pregnancy and Breastfeeding Warnings
Bisoprolol is also known as: Zebeta
Bisoprolol Pregnancy Warnings
Bisoprolol has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity. Increased rate of fetal resorptions were observed in rats at doses over 125 times the maximum recommended daily dose for humans (on a per kg basis). Embryo deaths were observed in rats at doses 31 times the maximum recommended daily dose for humans (on a per kg basis). There are no controlled data in human pregnancy. Bisoprolol should be given during pregnancy only when benefit outweighs risk.
In general, most experts recommend monitoring of neonates for signs and symptoms of beta-blockade, such as bradycardia and hypoglycemia.
Bisoprolol Breastfeeding Warnings
In general, most experts recommend monitoring of nursing infants for signs and symptoms of beta-blockade, such as bradycardia and hypoglycemia.
No data are available on the excretion of bisoprolol into human milk. The manufacturer recommends that caution be used when administering bisoprolol to nursing women.
- Bisoprolol use while Breastfeeding (in more detail)
- Bisoprolol Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.